179 related articles for article (PubMed ID: 21886838)
21. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.
Thedieck K; Polak P; Kim ML; Molle KD; Cohen A; Jenö P; Arrieumerlou C; Hall MN
PLoS One; 2007 Nov; 2(11):e1217. PubMed ID: 18030348
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer.
Basu A; Contreras AG; Datta D; Flynn E; Zeng L; Cohen HT; Briscoe DM; Pal S
Cancer Res; 2008 Jul; 68(14):5689-98. PubMed ID: 18632621
[TBL] [Abstract][Full Text] [Related]
23. Role of PRAS40 in Akt and mTOR signaling in health and disease.
Wiza C; Nascimento EB; Ouwens DM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
Carrière A; Cargnello M; Julien LA; Gao H; Bonneil E; Thibault P; Roux PP
Curr Biol; 2008 Sep; 18(17):1269-77. PubMed ID: 18722121
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
26. MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.
Zhang H; Wei P; Lv W; Han X; Yang J; Qin S; Zhang Y
Cell Transplant; 2019 Dec; 28(1_suppl):37S-50S. PubMed ID: 31813279
[TBL] [Abstract][Full Text] [Related]
27. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
28. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
[TBL] [Abstract][Full Text] [Related]
29. ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).
Carriere A; Romeo Y; Acosta-Jaquez HA; Moreau J; Bonneil E; Thibault P; Fingar DC; Roux PP
J Biol Chem; 2011 Jan; 286(1):567-77. PubMed ID: 21071439
[TBL] [Abstract][Full Text] [Related]
30. The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.
Inglis DJ; Lavranos TC; Beaumont DM; Leske AF; Brown CK; Hall AJ; Kremmidiotis G
Cancer Biol Ther; 2014; 15(11):1552-60. PubMed ID: 25482941
[TBL] [Abstract][Full Text] [Related]
31. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway.
Havel JJ; Li Z; Cheng D; Peng J; Fu H
Oncogene; 2015 Mar; 34(12):1487-98. PubMed ID: 24704832
[TBL] [Abstract][Full Text] [Related]
32. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.
Li J; Liu J; Song J; Wang X; Weiss HL; Townsend CM; Gao T; Evers BM
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C213-26. PubMed ID: 21508335
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
34. Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression.
Pal S; Datta K; Khosravi-Far R; Mukhopadhyay D
J Biol Chem; 2001 Jan; 276(4):2395-403. PubMed ID: 11060301
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
[TBL] [Abstract][Full Text] [Related]
36. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
37. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
38. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta.
Pal S; Claffey KP; Cohen HT; Mukhopadhyay D
J Biol Chem; 1998 Oct; 273(41):26277-80. PubMed ID: 9756852
[TBL] [Abstract][Full Text] [Related]
39. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth.
Wang S; Lu J; You Q; Huang H; Chen Y; Liu K
Oncotarget; 2016 Aug; 7(33):53269-53276. PubMed ID: 27458160
[TBL] [Abstract][Full Text] [Related]
40. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.
Wen ZH; Su YC; Lai PL; Zhang Y; Xu YF; Zhao A; Yao GY; Jia CH; Lin J; Xu S; Wang L; Wang XK; Liu AL; Jiang Y; Dai YF; Bai XC
Oncogene; 2013 Jan; 32(2):160-70. PubMed ID: 22349822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]